NOREEN MURPHY BOWENS: Open Payments
NPI 1669869210 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$725 in 34 payments from 9 companies in 2025. Trend: 2023 $1,190 · 2024 $764 · 2025 $725
Food & beverage: $725
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 9 | $192 |
| PFIZER INC. | 5 | $117 |
| Amgen Inc. | 6 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $108 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $78 |
| Merck Sharp & Dohme LLC | 3 | $65 |
| Abbott Laboratories | 1 | $22 |
| BridgeBio Pharma, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: REPATHA, LEQVIO, VYNDAQEL, CAMZYOS, JARDIANCE, ELIQUIS, VERQUVO, CARDIOMEMS.
Industry payments across DE — which companies pay providers there.
